FDA Issues Draft Guidance on Informed Consent for Sponsors, Investigators and Institutional Review Boards (IRBs) | Gardner Law

The U.S. Food and Drug Administration (FDA) recently issued a draft guidance document entitled, Key Information and Facilitating Understanding in Informed Consent. The draft guidance is...

Related Keywords

,Purpose Of The Research ,Treatments For Research ,Drug Administration ,Key Information ,Facilitating Understanding ,Common Rule ,Informed Consent ,Expected Duration ,Foreseeable Risks ,Medical Treatments ,